title: Improvement in pump function with endocardial biventricular pacing increases with activation time at the left ventricular pacing site in failing canine hearts.
abstract: Recently, attention has been focused on comparing left ventricular (LV) endocardial (ENDO) with epicardial (EPI) pacing for cardiac resynchronization therapy. However, the effects of ENDO and EPI lead placement at multiple sites have not been studied in failing hearts. We hypothesized that differences in the improvement of ventricular function due to ENDO vs. EPI pacing in dyssynchronous (DYSS) heart failure may depend on the position of the LV lead in relation to the original activation pattern. In six nonfailing and six failing dogs, electrical DYSS was created by atrioventricular sequential pacing of the right ventricular apex. ENDO was compared with EPI biventricular pacing at five LV sites. In failing hearts, increases in the maximum rate of LV pressure change (dP/dt; r = 0.64), ejection fraction (r = 0.49), and minimum dP/dt (r = 0.51), relative to DYSS, were positively correlated (P < 0.01) with activation time at the LV pacing site during ENDO but not EPI pacing. ENDO pacing at sites with longer activation delays led to greater improvements in hemodynamic parameters and was associated with an overall reduction in electrical DYSS compared with EPI pacing (P < 0.05). These findings were qualitatively similar for nonfailing hearts. Improvement in hemodynamic function increased with activation time at the LV pacing site during ENDO but not EPI pacing. At the anterolateral wall, end-systolic transmural function was greater with local ENDO compared with EPI pacing. ENDO pacing and intrinsic activation delay may have important implications for management of DYSS heart failure.
authors.affiliation: Department of Bioengineering, University of California San Diego, La Jolla, California 92093-0613, USA.
authors.forename: Elliot J
authors.initials: EJ
authors.lastname: Howard
authors.forename: James W
authors.initials: JW
authors.lastname: Covell
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Mulligan
authors.forename: Andrew D
authors.initials: AD
authors.lastname: McCulloch
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Omens
authors.forename: Roy C P
authors.initials: RC
authors.lastname: Kerckhoffs
mesh_terms: D000818:Animals; D001021:Aortic Valve / Q000502:physiology; D001696:Biomechanical Phenomena; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D002933:Cineradiography; D004285:Dogs; D004562:Electrocardiography; D004567:Electrodes, Implanted; D004699:Endocardium / Q000502:physiology*; D006321:Heart / Q000502:physiology*; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy*; D006352:Heart Ventricles; D006439:Hemodynamics / Q000502:physiology; D066298:In Vitro Techniques; D008943:Mitral Valve / Q000502:physiology; D016612:Paraffin Embedding; D013610:Tachycardia / Q000503:physiopathology; D016277:Ventricular Function, Left / Q000502:physiology; D016278:Ventricular Function, Right / Q000502:physiology